FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4226018889> ?p ?o ?g. }

• W4226018889 endingPage "786" @default.
• W4226018889 startingPage "779" @default.
• W4226018889 abstract "Abstract Cyclin-dependent kinase (CDK) 7-mediated phosphorylation of Mediator-complex subunit 1 (MED1) enhances androgen receptor (AR) activity in prostate cancer (PCa). Hyperactive AR-signalling plays a key role for the development of castration resistance. Several CDK7 inhibitors are currently under investigation in Phase I/II trials addressing solid tumours, including PCa. Aim of this study was to characterize the CDK7/phospho-(p)MED1 axis in human tissue. Immunohistochemistry was performed on 595 PCa samples including 394 primary tumour foci obtained by radical prostatectomy (RP), 64 advanced or recurrent tumours obtained by palliative transurethral resection of the prostate (pTUR), 65 lymph node metastases (LNM), 35 distant metastases (DM) and 36 benign samples. CDK7 is expressed in 79.3% of PCa tissues and protein levels are significantly higher in LNM, pTUR and DM and lower in benign tissues compared to primary tumours. CDK7 and pMED1 expression show strong positive correlation. High expression of CDK7 associated with shorter 5-year biochemical recurrence-free-survival (63.0% vs. 85.0%) and reduced survival persists when adjusted for T-Stage, nodal status, resection boundaries, grade group and pre-operative prostate-specific antigen in multivariate Cox-regression (hazard ratio 4.30; 95% CI, 1.43 to 12,40, P = 0.007). High CDK7 and pMED1 levels correlate with nuclear AR expression. CDK7 positive tumours harbour higher Ki67 expression indices and show more frequently positive ERG (ETS-related gene)-status. In conclusion, CDK7 is frequently expressed in human PCa and predicts disease recurrence after RP. Therapeutical inhibition of CDK7 might be a promising approach in treatment of advanced PCa." @default.
• W4226018889 created "2022-05-05" @default.
• W4226018889 creator A5011264291 @default.
• W4226018889 creator A5016588395 @default.
• W4226018889 creator A5016971686 @default.
• W4226018889 creator A5023457569 @default.
• W4226018889 creator A5027828579 @default.
• W4226018889 creator A5028072075 @default.
• W4226018889 creator A5031853343 @default.
• W4226018889 creator A5038778797 @default.
• W4226018889 creator A5044858557 @default.
• W4226018889 creator A5052466243 @default.
• W4226018889 creator A5055414788 @default.
• W4226018889 creator A5074979348 @default.
• W4226018889 creator A5077761103 @default.
• W4226018889 date "2022-05-05" @default.
• W4226018889 modified "2023-10-13" @default.
• W4226018889 title "Targeting cyclin-dependent kinase 7—association between CDK7 and pMED1 expression in prostate cancer tissue" @default.
• W4226018889 cites W1578291413 @default.
• W4226018889 cites W1963547267 @default.
• W4226018889 cites W1964471916 @default.
• W4226018889 cites W1977702358 @default.
• W4226018889 cites W1982109854 @default.
• W4226018889 cites W1984189354 @default.
• W4226018889 cites W2045673429 @default.
• W4226018889 cites W2046024621 @default.
• W4226018889 cites W2057194500 @default.
• W4226018889 cites W2075152619 @default.
• W4226018889 cites W2114104545 @default.
• W4226018889 cites W2123603532 @default.
• W4226018889 cites W2157755708 @default.
• W4226018889 cites W2171613528 @default.
• W4226018889 cites W2560322684 @default.
• W4226018889 cites W2890727330 @default.
• W4226018889 cites W2912991678 @default.
• W4226018889 cites W2970215199 @default.
• W4226018889 cites W3023627784 @default.
• W4226018889 cites W3192167153 @default.
• W4226018889 doi "https://doi.org/10.1093/carcin/bgac036" @default.
• W4226018889 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35512686" @default.
• W4226018889 hasPublicationYear "2022" @default.
• W4226018889 type Work @default.
• W4226018889 citedByCount "3" @default.
• W4226018889 countsByYear W42260188892022 @default.
• W4226018889 countsByYear W42260188892023 @default.
• W4226018889 crossrefType "journal-article" @default.
• W4226018889 hasAuthorship W4226018889A5011264291 @default.
• W4226018889 hasAuthorship W4226018889A5016588395 @default.
• W4226018889 hasAuthorship W4226018889A5016971686 @default.
• W4226018889 hasAuthorship W4226018889A5023457569 @default.
• W4226018889 hasAuthorship W4226018889A5027828579 @default.
• W4226018889 hasAuthorship W4226018889A5028072075 @default.
• W4226018889 hasAuthorship W4226018889A5031853343 @default.
• W4226018889 hasAuthorship W4226018889A5038778797 @default.
• W4226018889 hasAuthorship W4226018889A5044858557 @default.
• W4226018889 hasAuthorship W4226018889A5052466243 @default.
• W4226018889 hasAuthorship W4226018889A5055414788 @default.
• W4226018889 hasAuthorship W4226018889A5074979348 @default.
• W4226018889 hasAuthorship W4226018889A5077761103 @default.
• W4226018889 hasConcept C121608353 @default.
• W4226018889 hasConcept C124320809 @default.
• W4226018889 hasConcept C126322002 @default.
• W4226018889 hasConcept C143998085 @default.
• W4226018889 hasConcept C204232928 @default.
• W4226018889 hasConcept C2776235491 @default.
• W4226018889 hasConcept C2777008409 @default.
• W4226018889 hasConcept C2779466945 @default.
• W4226018889 hasConcept C2780192828 @default.
• W4226018889 hasConcept C29537977 @default.
• W4226018889 hasConcept C502942594 @default.
• W4226018889 hasConcept C71924100 @default.
• W4226018889 hasConcept C82495950 @default.
• W4226018889 hasConcept C94734110 @default.
• W4226018889 hasConceptScore W4226018889C121608353 @default.
• W4226018889 hasConceptScore W4226018889C124320809 @default.
• W4226018889 hasConceptScore W4226018889C126322002 @default.
• W4226018889 hasConceptScore W4226018889C143998085 @default.
• W4226018889 hasConceptScore W4226018889C204232928 @default.
• W4226018889 hasConceptScore W4226018889C2776235491 @default.
• W4226018889 hasConceptScore W4226018889C2777008409 @default.
• W4226018889 hasConceptScore W4226018889C2779466945 @default.
• W4226018889 hasConceptScore W4226018889C2780192828 @default.
• W4226018889 hasConceptScore W4226018889C29537977 @default.
• W4226018889 hasConceptScore W4226018889C502942594 @default.
• W4226018889 hasConceptScore W4226018889C71924100 @default.
• W4226018889 hasConceptScore W4226018889C82495950 @default.
• W4226018889 hasConceptScore W4226018889C94734110 @default.
• W4226018889 hasFunder F4320320879 @default.
• W4226018889 hasFunder F4320322725 @default.
• W4226018889 hasFunder F4320323556 @default.
• W4226018889 hasIssue "8" @default.
• W4226018889 hasLocation W42260188891 @default.
• W4226018889 hasLocation W42260188892 @default.
• W4226018889 hasOpenAccess W4226018889 @default.
• W4226018889 hasPrimaryLocation W42260188891 @default.
• W4226018889 hasRelatedWork W108895284 @default.
• W4226018889 hasRelatedWork W1995051622 @default.
• W4226018889 hasRelatedWork W2053319810 @default.

• next